CLINICAL_TRIALS
trial_result
· 2023-08-21
Clinical Trial Update: ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) [Phase 2]
Summary
A Phase 2 clinical trial update evaluating ABT-199 and Ibrutinib for Mantle Cell Lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN